Rare diseases
Investigational molecules
Locations
Back to Belgium441 clinical trials in Anderlecht, Belgium across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Baricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis
BelgiumPhase 3 Study of INCB123667 versus investigator's choice of chemotherapy drug combination in patients with platinum‑resistant ovarian cancer and cyclin E1 overexpression
BelgiumStudy of tarlatamab and durvalumab compared to durvalumab alone for patients with extensive stage small cell lung cancer
BelgiumA Study of Brelovitug Compared to Delayed Treatment in Patients with Chronic Hepatitis Delta Infection
BelgiumA Study of Mevrometostat and Enzalutamide for Men with Metastatic Castration-Sensitive Prostate Cancer Who Have Not Received Hormonal Therapy or Chemotherapy
BelgiumA Study of PF-07868489 Safety and Effectiveness in Adults with Pulmonary Arterial Hypertension Who Participated in a Previous PF-07868489 Trial
BelgiumLong-term study of sotatercept added to standard treatment in patients with pulmonary arterial hypertension
BelgiumStudy of datopotamab deruxtecan with or without durvalumab compared to standard treatment for patients with Stage I-III triple-negative breast cancer who have remaining cancer after initial therapy
BelgiumLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
BelgiumStudy of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.
BelgiumStudy of VS-01 with different treatment times compared to standard care alone in patients with overt hepatic encephalopathy and liver cirrhosis complications
BelgiumStudy of vicadrostat and empagliflozin given together or separately in people with chronic kidney disease to test safety and effectiveness
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials investigating new treatments for various cancers, including bladder cancer, acute myeloid leukemia, and advanced breast cancer. Studies focus on innovative combination therapies and targeted treatments.
Clinical investigations targeting chronic inflammatory conditions and autoimmune disorders, including Crohn's Disease, Ulcerative Colitis, and Psoriatic Arthritis.
Studies examining innovative approaches to combat various infections, including urinary tract infections and viral diseases. Research includes vaccine development and antimicrobial therapies.
Research focusing on pulmonary hypertension and cardiovascular disease management, with emphasis on innovative therapeutic approaches and disease prevention.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
